Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

被引:0
|
作者
Hwan-Ching Tai
Bo Y Wang
Alberto Serrano-Pozo
Matthew P Frosch
Tara L Spires-Jones
Bradley T Hyman
机构
[1] National Taiwan University,Department of Chemistry
[2] University of Iowa Hospitals & Clinics,Department of Neurology
[3] Harvard Medical School,C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital
[4] University of Edinburgh,Centre for Cognitive and Neural Systems and the Euan MacDonald Centre for Motor Neurone Disease
[5] Harvard Medical School,MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital
关键词
Point Spread Function; Synaptic Terminal; Tauopathy; Postsynaptic Terminal; Stereological Counting;
D O I
暂无
中图分类号
学科分类号
摘要
The accumulation of neurofibrillary tangles in Alzheimer’s disease (AD) propagates with characteristic spatiotemporal patterns which follow brain network connections, implying trans-synaptic transmission of tauopathy. Since misfolded tau has been shown to transmit across synapses in AD animal models, we hypothesized that synapses in AD patients may contain misfolded tau. By immunofluorescence imaging of bipartite synapses from AD subjects, we detected tau protein in 38.4% of presynaptic and 50.9% of postsynaptic terminals. The pre/post distribution for hyperphosphorylated tau was 26.9%/30.7%, and for misfolded tau 18.3%/19.3%. In the temporal cortex, microscopic aggregates of tau, containing ultra-stable oligomers, were estimated to accumulate within trillions of synapses, outnumbering macroscopic tau aggregates such as tangles by 10000 fold. Non-demented elderly also showed considerable synaptic tau hyperphosphorylation and some misfolding, implicating the synapse as one of the first subcellular compartments affected by tauopathy. Misfolding of tau protein appeared to occur in situ inside synaptic terminals, without mislocalizing or mistrafficking. Misfolded tau at synapses may represent early signs of neuronal degeneration, mediators of synaptotoxicity, and anatomical substrates for transmitting tauopathy, but its actual role in these processes remain to be elucidated.
引用
收藏
相关论文
共 50 条
  • [21] Postsynaptic receptors for arnyloid-β oligomers as mediators of neuronal damage in Alzheimer's disease
    Dinamarca, Margarita C.
    Rios, Juvenal A.
    Inestrosa, Nibaldo C.
    FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [22] Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology
    Bloemeke, Lara
    Rehn, Fabian
    Kraemer-Schulien, Victoria
    Kutzsche, Janine
    Pils, Marlene
    Bujnicki, Tuyen
    Lewczuk, Piotr
    Kornhuber, Johannes
    Freiesleben, Silka D.
    Schneider, Luisa-Sophie
    Preis, Lukas
    Priller, Josef
    Spruth, Eike J.
    Altenstein, Slawek
    Lohse, Andrea
    Schneider, Anja
    Fliessbach, Klaus
    Wiltfang, Jens
    Hansen, Niels
    Rostamzadeh, Ayda
    Duezel, Emrah
    Glanz, Wenzel
    Incesoy, Enise I.
    Butryn, Michaela
    Buerger, Katharina
    Janowitz, Daniel
    Ewers, Michael
    Perneczky, Robert
    Rauchmann, Boris-Stephan
    Teipel, Stefan
    Kilimann, Ingo
    Goerss, Doreen
    Laske, Christoph
    Munk, Matthias H.
    Sanzenbacher, Carolin
    Spottke, Annika
    Roy-Kluth, Nina
    Heneka, Michael T.
    Brosseron, Frederic
    Wagner, Michael
    Wolfsgruber, Steffen
    Kleineidam, Luca
    Stark, Melina
    Schmid, Matthias
    Jessen, Frank
    Bannach, Oliver
    Willbold, Dieter
    Peters, Oliver
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (02)
  • [23] Heterogeneous Tau Oligomers as Molecular Targets for Alzheimer's Disease and Related Tauopathies
    Lo, Chih Hung
    BIOPHYSICA, 2022, 2 (04): : 440 - 451
  • [24] Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease
    Vander Zanden, Crystal M.
    Chi, Eva Y.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (01) : 68 - 73
  • [25] Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies
    Castillo-Carranza, Diana L.
    Nilson, Ashley N.
    Van Skike, Candice E.
    Jahrling, Jordan B.
    Patel, Kishan
    Garach, Prajesh
    Gerson, Julia E.
    Sengupta, Urmi
    Abisambra, Jose
    Nelson, Peter
    Troncoso, Juan
    Ungvari, Zoltan
    Galvan, Veronica
    Kayed, Rakez
    AGING AND DISEASE, 2017, 8 (03): : 257 - 266
  • [26] Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
    De Felice, Fernanda G.
    Wu, Diana
    Lambert, Mary P.
    Fernandez, Sara J.
    Velasco, Pauline T.
    Lacor, Pascale N.
    Bigio, Eileen H.
    Jerecic, Jasna
    Acton, Paul J.
    Shughrue, Paul J.
    Chen-Dodson, Elizabeth
    Kinney, Gene G.
    Klein, William L.
    NEUROBIOLOGY OF AGING, 2008, 29 (09) : 1334 - 1347
  • [27] The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD)
    Mroczko, Barbara
    Groblewska, Magdalena
    Litman-Zawadzka, Ala
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [28] Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals
    Honer, WG
    NEUROBIOLOGY OF AGING, 2003, 24 (08) : 1047 - 1062
  • [29] APOE ε4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
    Lai, M. K. P.
    Tsang, S. W. Y.
    Garcia-Alloza, M.
    Minger, S. L.
    Nicoll, J. A. R.
    Esiri, M. M.
    Wong, P. T-H
    Chen, C. P. L-H
    Ramirez, M. J.
    Francis, P. T.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 18 - 18
  • [30] Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease
    Kurucu, Hatice
    Colom-Cadena, Marti
    Davies, Caitlin
    Wilkins, Lewis
    King, Declan
    Rose, Jamie
    Tzioras, Makis
    Tulloch, Jane H.
    Smith, Colin
    Spires-Jones, Tara L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (05) : 1311 - 1323